• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

NIHR Oxford Health Biomedical Research Centre

MENUMENU
  • About
    • About
    • Management and core team
    • Our partners
    • Timeline of our key achievements
    • Core facilities
    • Work with us
    • Contact
  • Departments
    • NIHR Oxford Cognitive Health Clinical Research Facility
    • Brain Health Centre
    • Oxford Precision Psychiatry Lab (OxPPL)
    • Oxford Dementia and Ageing Research (OxDARE)
    • Treatment Resistant Depression Clinic
    • Experimental Medicine and Industry Partnership (EMIP)
  • Research Themes
    • Better Sleep
    • Brain Technologies
    • Data Science
    • Dementia
    • Depression Therapeutics
    • Flourishing & Wellbeing
    • Mental Health in Development
    • Molecular Targets
    • Pain
    • Preventing Multiple Morbidities
    • Psychological Treatments
  • COVID-19 Research
    • Overview
    • News
    • COVID-19 & clinical management of mental health issues
  • News & Events
    • News
    • Training and Events
    • Psychiatry Department Seminars
  • Patients & Public
    • About Patient and Public Involvement
    • Shape our research
    • Take part in our research
    • Resources for researchers
    • Resources for the public
    • Patient and Public Involvement Strategy
    • Young people’s involvement
  • Training Hub
You are here: Home / Research Themes / Theme Leads / Profile: Susannah Murphy

Profile: Susannah Murphy

NIHR Oxford Health and BRC Senior Research Fellow, University of Oxford

Deputy Theme Lead: Clinical research infrastructure / experimental medicine

Email: susannah.murphy@psych.ox.ac.uk


I am a NIHR BRC Senior Research Fellow in the Department of Psychiatry, University of Oxford. I graduated with an undergraduate Psychology degree from St Andrews University and was then awarded a Wellcome Trust Neuroscience scholarship to complete an MSc and DPhil at the University of Oxford. My doctoral work consisted of a series of behavioural and functional magnetic resonance imaging (fMRI) studies that were pivotal in demonstrating that antidepressants have effects on emotion-related cognition that can be quantified using computerised behavioural tasks and neuroimaging. My current research uses a translational experimental medicine approach to provide an early assessment of novel treatment approaches for depression and anxiety in humans. By developing and using proximal intermediate outcomes, such as the early effect of a treatment on key cognitive processes, it is possible to characterise the likely mechanisms of a novel treatment target and predict later treatment efficacy. Using this approach, I have active programs of work characterising the neuropsychological effects of novel antidepressant targets, including ketamine and the 5-HT4 receptor. I work with a number of pharmaceutical companies (e.g. UCB Pharma; Johnson & Johnson; Pfizer) who recognise the value of deploying this experimental medicine approach in the drug development process.

View Susannah Murphy’s profile on the Department of Psychiatry website.

Primary Sidebar

  • Theme Leads Overview
  • Profile: Paul Harrison
  • Profile: Elizabeth Tunbridge
  • Profile: Clare Mackay
  • Profile: Vanessa Raymont
  • Profile: Anke Ehlers
  • Profile: Daniel Freeman
  • Profile: Catherine Harmer
  • Profile: Susannah Murphy
  • Profile: Andrea Cipriani
  • Profile: Kate Saunders
  • Profile: Kia Nobre
  • Profile: Mark Woolrich
  • Profile: Ilina Singh

Footer

Follow us

  • LinkedIn
  • Twitter
  • YouTube

Improving brain health: the future in mind

The National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) is a partnership between Oxford Health NHS Foundation Trust and the University of Oxford.  We are part of the Oxford Academic Health Partners.
Oxford Academic Health Partners
  • Sitemap
  • Accessibility
  • Disclaimer
  • Cookies
  • Contact

© 2023 NIHR Oxford Health Biomedical Research Centre · Log in

Cookies

This site uses cookies: See our privacy policy